{"transactions":[{"id":1552966,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T16:34:29.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":1358,"price":8.1,"value":10999.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2024."}],"balance_after":22075,"source":{"system":"sec-edgar","filing":"0001662579-24-000037","document":"wk-form4_1712090040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257924000037/wk-form4_1712090040.xml","form_type":"4"}},{"id":1691403,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T16:12:59.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1687,"price":6.52,"value":10999.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2024."}],"balance_after":20717,"source":{"system":"sec-edgar","filing":"0001662579-24-000006","document":"wk-form4_1704316341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257924000006/wk-form4_1704316341.xml","form_type":"4"}},{"id":1766814,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T16:27:34.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":6470,"price":1.7,"value":10999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023."}],"balance_after":19030,"source":{"system":"sec-edgar","filing":"0001662579-23-000108","document":"wk-form4_1696364836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257923000108/wk-form4_1696364836.xml","form_type":"4"}},{"id":1835449,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T16:24:42.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":3887,"price":2.83,"value":11000.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on  July 3, 2023."}],"balance_after":12560,"source":{"system":"sec-edgar","filing":"0001662579-23-000067","document":"wk-form4_1688588669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257923000067/wk-form4_1688588669.xml","form_type":"4"}},{"id":1851700,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:23:56.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":26000,"derivative":{"exercise_price":3.61,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001662579-23-000059","document":"wk-form4_1686947027.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257923000059/wk-form4_1686947027.xml","form_type":"4"}},{"id":1927249,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T16:20:05.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":3438,"price":3.2,"value":11001.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 3, 2023."}],"balance_after":8673,"source":{"system":"sec-edgar","filing":"0001662579-23-000046","document":"wf-form4_168063957956687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257923000046/wf-form4_168063957956687.xml","form_type":"4"}},{"id":2066294,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T16:16:11.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1725,"price":6.38,"value":11005.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 3, 2023."}],"balance_after":5235,"source":{"system":"sec-edgar","filing":"0001662579-23-000004","document":"wf-form4_167286693048091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257923000004/wf-form4_167286693048091.xml","form_type":"4"}},{"id":2143950,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T18:06:00.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":1265,"price":8.69,"value":10992.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 3, 2022."}],"balance_after":3510,"source":{"system":"sec-edgar","filing":"0001662579-22-000005","document":"wf-form4_166492113147782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000166257922000005/wf-form4_166492113147782.xml","form_type":"4"}},{"id":2214134,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-05T16:12:47.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":1372,"price":8.03,"value":11017.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2022."}],"balance_after":2245,"source":{"system":"sec-edgar","filing":"0001209191-22-040603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919122040603/doc4.xml","form_type":"4"}},{"id":2222841,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T16:16:01.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":6.06,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-22-038864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919122038864/doc4.xml","form_type":"4"}},{"id":2303839,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T16:27:20.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":379,"price":26.46,"value":10028.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 4, 2022."}],"balance_after":873,"source":{"system":"sec-edgar","filing":"0001209191-22-023021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919122023021/doc4.xml","form_type":"4"}},{"id":2433481,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T16:30:37.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":199,"price":31.58,"value":6284.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022."}],"balance_after":494,"source":{"system":"sec-edgar","filing":"0001209191-22-003502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919122003502/doc4.xml","form_type":"4"}},{"id":2548372,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:55:59.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":138,"price":44.99,"value":6208.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021."}],"balance_after":295,"source":{"system":"sec-edgar","filing":"0001209191-21-059526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919121059526/doc4.xml","form_type":"4"}},{"id":2594599,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T16:30:24.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":157,"price":39.72,"value":6236.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021."}],"balance_after":157,"source":{"system":"sec-edgar","filing":"0001209191-21-052780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919121052780/doc4.xml","form_type":"4"}},{"id":2785748,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":92347,"kind":"person","name":"Dubin Glenn","position":1,"cik":"0001308597","reported_name":"Dubin Glenn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-16T16:17:42.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option shall vest and become exercisable on March 12, 2022, with the remainder vesting in eight equal quarterly installments thereafter."}],"balance_after":41200,"derivative":{"exercise_price":44.64,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0001209191-21-020777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308597/000120919121020777/doc4.xml","form_type":"4"}}]}